Shrinkage of inoperable adenomas in cavernous sinus with high-dose octreotide.
Donckier
J
J
Gilliard
C
C
Buysschaert
M
M
D000236:Adenoma / Q000188:drug therapy*; D002426:Cavernous Sinus; D005260:Female; D006801:Humans; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D014652:Vascular Diseases / Q000188:drug therapy
D015282:Octreotide